Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhengqingfengtongning for herpes zoster neuralgia
ChiCTR-IPR-17012328Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of zhengqing fengtongning, pregabalin and gabapentin in postherpetic neuralgia (PHN) (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: Pain visual analogue scale, ID Pain scale and 1 more. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
zhengqing fengtongningpregabalingabapentin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR-IPR-17012328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012328.